I.M. Sechenov First Moscow State Medical University

Moscow 119991

0 studies enrolling now · 6 studies all time

What they study most

Dermatomyositis, Heart Diseases, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Prostatic Neoplasms, Rheumatoid Arthritis, Urothelial Cancer, Ventricular Tachycardia

Studies at this site

• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
• A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer — Running, not enrolling
• Application of High Power Radio Frequency Energy in the Ventricular Tachycardia Treatment — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) — Completed
• Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) — Completed